Differential Sensitivity of Germline and Somatic BRCA Variants to PARP Inhibitor in High-Grade Serous Ovarian Cancer.
Julie A VendrellIulian O BanIsabelle SolassolPatricia AudranSimon Cabello-AguilarDelphine TopartClothilde Lindet-BourgeoisPierre-Emmanuel ColomboEric LegouffeVeronique D'HondtMichel FabbroJean-Marc ReyPublished in: International journal of molecular sciences (2023)
alterations could provide valuable information for improving management strategies and predicting the outcome of patients with HGSOC.